Glycobiology Advance Access originally published online on July 9, 2007
Glycobiology 2007 17(10):1061-1069; doi:10.1093/glycob/cwm074
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VIPL has sugar-binding activity specific for high-mannose-type N-glycans, and glucosylation of the
1,2 mannotriosyl branch blocks its binding
2 Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Bioscience BLD 602, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8562, Japan
3 RIKEN, Saitama 351-0198, Japan
4 CREST, JST, Saitama 332-1102, Japan
1 To whom correspondence should be addressed; Tel: +81-4-7136-3614; Fax: +81-4-7136-3619; e-mail: yamamoto{at}k.u-tokyo.ac.jp
Received on February 9, 2007; revised on July 1, 2007; accepted on July 1, 2007
VIP36-like protein (VIPL) was identified as an endoplasmic reticulum (ER) resident protein with homology to VIP36, a cargo receptor involved in the transport of glycoproteins within cells. Although VIPL is structurally similar to VIP36, VIPL is thought not to be a lectin, because its sugar-binding activity has not been detected in several experiments. Here, recombinant soluble VIPL proteins (sVIPL) were expressed in Escherichia coli, biotinylated with biotin ligase and oligomerized with R-phycoerythrin (PE)-labeled streptavidin (SA). As measured with flow cytometry, PE-labeled sVIPL–SA bound to deoxymannojirimycin (DMJ)- or kifunensine (KIF)- but not to swainsonine (SW)-treated HeLaS3 cells in the presence of calcium. A surface plasmon resonance analysis showed that the avidity of sVIPL was enhanced after it formed a complex with SA. The binding of PE-labeled sVIPL–SA was abrogated by endo ß-N-acetylglucosaminidase H treatment of the DMJ- or KIF-treated cells. Competition with several high-mannose-type N-glycans inhibited VIPL binding, and indicated that VIPL recognizes the Man
1–2Man
1–2Man sequence. Glucosylation of the outer mannose residue of this portion decreased the binding. Although the biochemical characteristics of VIPL are similar to those of VIP36, the sugar-binding activity of VIPL was stronger at neutral pH, corresponding to the pH in the lumen of the ER, than under acidic conditions.
Key words: high mannose type / lectin / N-glycan / VIPL
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Kawasaki, Y. Ichikawa, I. Matsuo, K. Totani, N. Matsumoto, Y. Ito, and K. Yamamoto The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2 Blood, February 15, 2008; 111(4): 1972 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kamiya, D. Kamiya, K. Yamamoto, B. Nyfeler, H.-P. Hauri, and K. Kato Molecular Basis of Sugar Recognition by the Human L-type Lectins ERGIC-53, VIPL, and VIP36 J. Biol. Chem., January 25, 2008; 283(4): 1857 - 1861. [Abstract] [Full Text] [PDF] |
||||

